1. Home
  2. ARDX vs MBWM Comparison

ARDX vs MBWM Comparison

Compare ARDX & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • MBWM
  • Stock Information
  • Founded
  • ARDX 2007
  • MBWM 1997
  • Country
  • ARDX United States
  • MBWM United States
  • Employees
  • ARDX N/A
  • MBWM N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • MBWM Major Banks
  • Sector
  • ARDX Health Care
  • MBWM Finance
  • Exchange
  • ARDX Nasdaq
  • MBWM Nasdaq
  • Market Cap
  • ARDX 882.9M
  • MBWM 763.7M
  • IPO Year
  • ARDX 2014
  • MBWM 1997
  • Fundamental
  • Price
  • ARDX $5.55
  • MBWM $44.79
  • Analyst Decision
  • ARDX Strong Buy
  • MBWM Buy
  • Analyst Count
  • ARDX 9
  • MBWM 4
  • Target Price
  • ARDX $10.50
  • MBWM $53.63
  • AVG Volume (30 Days)
  • ARDX 3.1M
  • MBWM 50.5K
  • Earning Date
  • ARDX 10-30-2025
  • MBWM 10-14-2025
  • Dividend Yield
  • ARDX N/A
  • MBWM 3.29%
  • EPS Growth
  • ARDX N/A
  • MBWM N/A
  • EPS
  • ARDX N/A
  • MBWM 5.03
  • Revenue
  • ARDX $386,146,000.00
  • MBWM $228,384,000.00
  • Revenue This Year
  • ARDX $17.79
  • MBWM $10.34
  • Revenue Next Year
  • ARDX $27.82
  • MBWM $11.93
  • P/E Ratio
  • ARDX N/A
  • MBWM $8.95
  • Revenue Growth
  • ARDX 83.88
  • MBWM 3.70
  • 52 Week Low
  • ARDX $3.21
  • MBWM $37.76
  • 52 Week High
  • ARDX $7.04
  • MBWM $52.98
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 34.81
  • MBWM 34.43
  • Support Level
  • ARDX $5.49
  • MBWM $46.35
  • Resistance Level
  • ARDX $6.78
  • MBWM $46.28
  • Average True Range (ATR)
  • ARDX 0.21
  • MBWM 1.20
  • MACD
  • ARDX -0.15
  • MBWM -0.32
  • Stochastic Oscillator
  • ARDX 5.02
  • MBWM 11.29

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

Share on Social Networks: